Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Nasopharyngeal Neoplasms × fosaprepitant × Clear all

Sponsor

Conditions

Vomiting 6 Nausea 3 Neoplasms 2 Uterine Neoplasms 1 Testicular Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Ovarian Neoplasms 1 Neoplasms, Germ Cell and Embryonal 1 Multiple Myeloma 1 Melanoma 1 Gynecologic Cancer 1 Gastrointestinal Neoplasms 1 Carcinoma, Renal Cell 1

Interventions

pembrolizumab 4 Gemcitabine 2 Docetaxel 2 Cisplatin 2 Carboplatin 2 Bupropion 2 tocilizumab 1 tislelizumab 1 spartalizumab 1 infigratinib 1 etoposide phosphate 1 cc-486 1 avelumab 1 Zoledronic Acid 1 Vorinostat 1 Tobacco Use Cessation Devices 1 Psychiatric Rehabilitation 1 Polymerase Chain Reaction 1 Pilocarpine 1 Oral Hygiene 1 Ifosfamide 1 Gene Expression Profiling 1 Fluorouracil 1 Fluorodeoxyglucose F18 1 FPP(RGD)2 1 Etoposide 1 Early Intervention, Educational 1 Dexamethasone 1 Counseling 1 Cetuximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡